85 related articles for article (PubMed ID: 12372539)
1. Conformational restraint is a critical determinant of unnatural nucleotide recognition by protein kinases.
Ulrich SM; Sallee NA; Shokat KM
Bioorg Med Chem Lett; 2002 Nov; 12(21):3223-7. PubMed ID: 12372539
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor scaffolds as new allele specific kinase substrates.
Kraybill BC; Elkin LL; Blethrow JD; Morgan DO; Shokat KM
J Am Chem Soc; 2002 Oct; 124(41):12118-28. PubMed ID: 12371851
[TBL] [Abstract][Full Text] [Related]
3. Engineering a "methionine clamp" into Src family kinases enhances specificity toward unnatural ATP analogues.
Ulrich SM; Kenski DM; Shokat KM
Biochemistry; 2003 Jul; 42(26):7915-21. PubMed ID: 12834343
[TBL] [Abstract][Full Text] [Related]
4. A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src.
Liu Y; Shah K; Yang F; Witucki L; Shokat KM
Bioorg Med Chem; 1998 Aug; 6(8):1219-26. PubMed ID: 9784863
[TBL] [Abstract][Full Text] [Related]
5. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho.
Pfeiffer ZA; Aga M; Prabhu U; Watters JJ; Hall DJ; Bertics PJ
J Leukoc Biol; 2004 Jun; 75(6):1173-82. PubMed ID: 15075366
[TBL] [Abstract][Full Text] [Related]
6. Kinetic mechanism and ATP-binding site reactivity of p38gamma MAP kinase.
Fox T; Fitzgibbon MJ; Fleming MA; Hsiao HM; Brummel CL; Su MS
FEBS Lett; 1999 Nov; 461(3):323-8. PubMed ID: 10567720
[TBL] [Abstract][Full Text] [Related]
7. Engineering the serine/threonine protein kinase Raf-1 to utilise an orthogonal analogue of ATP substituted at the N6 position.
Hindley AD; Park S; Wang L; Shah K; Wang Y; Hu X; Shokat KM; Kolch W; Sedivy JM; Yeung KC
FEBS Lett; 2004 Jan; 556(1-3):26-34. PubMed ID: 14706820
[TBL] [Abstract][Full Text] [Related]
8. Configuration of the active Mg-ATP complex in protein kinase C reaction.
Kondo H; Kinoshita J; Matsuba T; Sunamoto J
FEBS Lett; 1986 May; 201(1):94-6. PubMed ID: 3486784
[TBL] [Abstract][Full Text] [Related]
9. Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors.
Peifer C; Urich R; Schattel V; Abadleh M; Röttig M; Kohlbacher O; Laufer S
Bioorg Med Chem Lett; 2008 Feb; 18(4):1431-5. PubMed ID: 18207396
[TBL] [Abstract][Full Text] [Related]
10. Stimulation by extracellular ATP and UTP of the stress-activated protein kinase cascade in rat renal mesangial cells.
Huwiler A; van Rossum G; Wartmann M; Pfeilschifter J
Br J Pharmacol; 1997 Mar; 120(5):807-12. PubMed ID: 9138685
[TBL] [Abstract][Full Text] [Related]
11. [Interaction of N1-, N6- and C8-substituted derivatives of adenosine-5'-triphosphate with the catalytic subunit of cAMP-dependent protein kinase from rabbit skeletal muscles].
Baranova LA; Grivennikov IA; Guliaev NN
Biokhimiia; 1982 Nov; 47(11):1806-13. PubMed ID: 6295513
[TBL] [Abstract][Full Text] [Related]
12. Src-Abl tyrosine kinase chimeras: replacement of the adenine binding pocket of c-Abl with v-Src to swap nucleotide and inhibitor specificities.
Liu Y; Witucki LA; Shah K; Bishop AC; Shokat KM
Biochemistry; 2000 Nov; 39(47):14400-8. PubMed ID: 11087392
[TBL] [Abstract][Full Text] [Related]
13. Catalytic mechanisms and regulation of protein kinases.
Wang Z; Cole PA
Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640
[TBL] [Abstract][Full Text] [Related]
14. The NTP phosphate donor in kinase reactions: is ATP a monopolist?
Shugar D
Acta Biochim Pol; 1996; 43(1):9-23. PubMed ID: 8790708
[TBL] [Abstract][Full Text] [Related]
15. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.
Johnson RA; Huong SM; Huang ES
J Virol; 2000 Feb; 74(3):1158-67. PubMed ID: 10627526
[TBL] [Abstract][Full Text] [Related]
16. The kinetics of binding to p38MAP kinase by analogues of BIRB 796.
Regan J; Pargellis CA; Cirillo PF; Gilmore T; Hickey ER; Peet GW; Proto A; Swinamer A; Moss N
Bioorg Med Chem Lett; 2003 Sep; 13(18):3101-4. PubMed ID: 12941343
[TBL] [Abstract][Full Text] [Related]
17. Stimulation by the nucleotides, ATP and UTP of mitogen-activated protein kinase in EAhy 926 endothelial cells.
Graham A; McLees A; Kennedy C; Gould GW; Plevin R
Br J Pharmacol; 1996 Mar; 117(6):1341-7. PubMed ID: 8882634
[TBL] [Abstract][Full Text] [Related]
18. ATP analog specificity of cAMP-dependent protein kinase, cGMP-dependent protein kinase, and phosphorylase kinase.
Flockhart DA; Freist W; Hoppe J; Lincoln TM; Corbin JD
Eur J Biochem; 1984 Apr; 140(2):289-95. PubMed ID: 6325182
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
[TBL] [Abstract][Full Text] [Related]
20. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle.
Lemieux K; Konrad D; Klip A; Marette A
FASEB J; 2003 Sep; 17(12):1658-65. PubMed ID: 12958172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
